One-liner: “AiCella develops AI-driven solutions for the CAR-T therapy market, assisting pharmaceutical and biotech companies in process development and regulatory compliance.”
Company slogan: “Unlocking Precision, Empowering Immunity: AiCella, Where AI Fuels Cellular Innovation”
Positioning: “AiCella is positioned as a provider of AI-driven solutions specifically tailored for the CAR-T therapy market, focusing on process development and regulatory compliance.”
Description: “At Aicella, we’re at the forefront of revolutionizing CAR-T therapy development. The soaring demand for personalized cancer treatments has propelled us to create innovative tools that streamline processes, reduce bottlenecks, and significantly enhance patient outcomes. Our InsightsTM data dashboard stands as a beacon of efficient process design and analysis, catering to the evolving needs of the global CAR-T therapy market.”
Employees: 3
Website: Visit websiteHeadquarters: “San Diego, California”
Ownership: Privately Held
Founded: 2023
Company type: AI company
Use cases: “CAR-T therapy development, process optimization in cell therapy, regulatory compliance in therapeutics”
Pricing: custom pricing based on services offered
Client sector: “pharmaceutical companies, biotech firms, research institutions, academic centers”
Business model: subscription and service-based
Products: “Aicella Insights TM, AI/ML Data Dashboard”
Is API available: no
Website title: “Unlocking Precision, Empowering Immunity: AiCella, Where AI Fuels Cellular Innovation”
Website description: none
Linkedin: https://www.linkedin.com/company/aicella
Youtube: https://www.youtube.com/channel/UCWscuDREFRhbOJB-4941hiQ
Instagram: –
Facebook: –
Twitter: –
Crunchbase: –
Email: info@aicella.com